We are excited to announce this new webcast on emerging pharmacological solutions for management of metabolic disruptions in patients with schizophrenia.
With a focus on appraisal of clinical profiles of novel and emerging antipsychotic agents, this accredited webcast outlines potential strategies to mitigate adverse effects and improve medication adherence rates among patients with schizophrenia.
This activity is designed for psychiatrists, primary care physicians, psychologists, nurse practitioners, physician assistants, psychiatric nurses, and other healthcare professionals who seek to improve the care of patients with mental health disorders.
After participating in this activity, learners should be better able to:
To be eligible for credit, participants must complete the online activity and the evaluation. Upon completing the activity, there will be instructions on how to complete the evaluation and print a certificate or other documentation of credit.
Release Date: June 30, 2021
Expiration Date: June 30, 2022
Estimated Time to Complete: 45 minutes